Skip to main content
Ikonisys S.A. logo

Ikonisys S.A. — Investor Relations & Filings

Ticker · ALIKO ISIN · FR00140048X2 LEI · 9695000B742KPNDQ4D05 PA Manufacturing
Open in API
Filings indexed 195 across all filing types
Latest filing 2022-05-24 Regulatory Filings
Country FR France
Listing PA ALIKO

About Ikonisys S.A.

https://www.ikonisys.com

Ikonisys S.A. is a cell-based diagnostics company specializing in Fluorescence in Situ Hybridization (FISH) technology for genetic analysis. The company develops, manufactures, and markets integrated solutions that include proprietary automated microscopy instruments, advanced software, and reagents. These systems are designed to improve efficiency, accuracy, and standardization for pathologists and laboratory technicians. Ikonisys's technology enables the precise detection and analysis of chromosomal alterations, supporting early and accurate cancer diagnosis, prognosis, and the selection and monitoring of personalized therapies. The platform's automation and digitization features streamline the entire workflow from image acquisition to quantitative interpretation for oncology and genetic testing applications.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release dated May 24, 2022, announcing a new research contract between Ikonisys SA and Politecnico di Milano regarding deep learning models for cell detection. This type of announcement, detailing a strategic partnership, research activity, or business development that is not a formal financial report (like 10-K, IR, or ER), typically falls under general corporate news or regulatory updates. Since it is a specific announcement about a strategic business development (research contract) rather than a mandatory financial filing, and it doesn't fit the definitions for M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), the most appropriate category is Regulatory Filings (RNS) as a general announcement, or potentially Investor Presentation (IP) if it were a presentation, but it reads like a press release. Given the options, and that it is a specific, non-financial operational announcement, RNS serves as the best fit for general corporate news releases that aren't covered by more specific codes. However, since it details a significant operational/strategic development, it is often classified as a general corporate announcement. Given the available codes, RNS is the fallback for miscellaneous regulatory announcements. If the document were an Investor Presentation (IP), it would be much longer and structured differently. Since it is a press release announcing a contract, RNS is the most suitable general regulatory/corporate announcement category.
2022-05-24 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated May 24, 2022, announcing that Ikonisys has signed a research agreement with Politecnico di Milano to develop a deep learning model for cell identification. This type of announcement, detailing a strategic partnership, collaboration, or significant business development that is not a standard periodic financial report (like 10-K or IR) or a specific corporate action (like dividend or share buyback), typically falls under general corporate news or regulatory announcements. Since it is a formal announcement of a business development and not a financial filing, and it doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), the most appropriate classification is the general regulatory/corporate announcement category, RNS, as it serves as a broad disclosure of material, non-financial corporate activity. It is not an Earnings Release (ER) or a Call Transcript (CT). Given the content is a formal press release about a strategic agreement, RNS is the best fit among the provided options for general corporate news disclosure.
2022-05-24 French
Inside Information / Other news releases
Regulatory Filings Classification · 90% confidence The document is a press release dated May 12, 2022, announcing a collaboration agreement between Ikonisys SA and Evosciences Leasing to support the commercial expansion of the Ikoniscope20 system. It details a strategic partnership focused on financing options for customers. This type of announcement, which details a significant business development, partnership, or strategic move, is typically classified as a general business update or regulatory filing. Since it is not a formal financial report (10-K, IR, ER, MRQ), a management discussion (MDA), a capital event (CAP, SHA), or a specific legal/governance filing, the most appropriate category is the general Regulatory Filings (RNS) or potentially a Capital/Financing Update (CAP) if the focus was purely on the financing structure. However, the core announcement is the strategic partnership for commercial expansion, which fits best under the broad 'Regulatory Filings' (RNS) category as a general market announcement, or potentially 'LTR' if it were a legal proceeding, but it is not. Given the nature of a press release announcing a strategic commercial agreement, RNS is the best fit among the provided options, as it is a general regulatory announcement not covered by more specific codes like DIV, ER, or 10-K. It is not short enough to be an RPA.
2022-05-12 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated May 12, 2022, announcing a partnership between Ikonisys SA and Evosciences Leasing to support the commercial expansion of the Ikoniscope20 platform in Europe and the US. It details the partnership's purpose (financing options for clients) and provides company background information and contact details. This type of announcement, which is a formal communication about a business development (a strategic partnership and financing arrangement) but is not a mandatory regulatory filing like a 10-K, earnings release (ER), or a specific capital change notice, fits best under the general category for corporate news announcements that don't fit elsewhere, which is Regulatory Filings (RNS) in this context, or potentially a general announcement related to financing (CAP). However, since it is primarily a press release announcing a strategic business development and partnership, and not a direct report of financing terms or capital structure change itself, RNS is the most appropriate general classification for non-standard corporate news releases.
2022-05-12 French
Inside Information / Other news releases
Capital/Financing Update Classification · 99% confidence The document explicitly announces that Ikonisys has 'signed a financing agreement of up to €6m' in the form of convertible bonds (OCA) with attached warrants (BSA). This content directly relates to fundraising, capital structure changes, and financing activities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA), but the substance of the financing deal itself.
2022-05-04 English
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 99% confidence The document is a press release from Ikonisys SA announcing the conclusion of a financing agreement (up to 6 M€) structured through convertible bonds with warrants attached (OCABSA). This type of announcement, detailing fundraising, capital structure changes, and the terms of debt/equity instruments, directly corresponds to the definition of a Capital/Financing Update. The text explicitly mentions 'accord de financement' (financing agreement), 'obligations convertibles en actions nouvelles' (convertible bonds), and the purpose is to provide 'ressources supplémentaires pour accélérer sa stratégie de commercialisation'. This strongly aligns with the 'CAP' code. It is not an Annual Report (10-K), an Earnings Release (ER), or a simple Report Publication Announcement (RPA), as it contains the substance of the financing deal itself, not just a notice that a report is available.
2022-05-04 French

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.